James E Murray - Net Worth and Insider Trading

James E Murray Net Worth

The estimated net worth of James E Murray is at least $23 Million dollars as of 2024-04-23. James E Murray is the EVP & COO of Humana Inc and owns about 37,758 shares of Humana Inc (HUM) stock worth over $12 Million. James E Murray is the EVP, COO of Centene Corp and owns about 136,250 shares of Centene Corp (CNC) stock worth over $10 Million. James E Murray is also the President and COO of Magellan Health Inc and owns about 4,500 shares of Magellan Health Inc (MGLN) stock worth over $427,455. Details can be seen in James E Murray's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James E Murray has not made any transactions after 2023-02-08 and currently still holds the listed stock(s).

Transaction Summary of James E Murray

To

James E Murray Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James E Murray owns 3 companies in total, including Magellan Health Inc () , Humana Inc () , and Centene Corp () .

Click here to see the complete history of James E Murray’s form 4 insider trades.

Insider Ownership Summary of James E Murray

Ticker Comapny Transaction Date Type of Owner
Magellan Health Inc 2020-05-15 President and COO
Humana Inc 2017-03-06 COO-Mkt & Bus. Segment Ops
Centene Corp 2023-02-08 EVP & Chief Transform. Officer

James E Murray Latest Holdings Summary

James E Murray currently owns a total of 3 stocks. Among these stocks, James E Murray owns 37,758 shares of Humana Inc (HUM) as of March 6, 2017, with a value of $12 Million and a weighting of 53.38%. James E Murray owns 136,250 shares of Centene Corp (CNC) as of February 8, 2023, with a value of $10 Million and a weighting of 44.76%. James E Murray also owns 4,500 shares of Magellan Health Inc (MGLN) as of May 15, 2020, with a value of $427,455 and a weighting of 1.86%.

Latest Holdings of James E Murray

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HUM Humana Inc 2017-03-06 37,758 325.30 12,282,677
CNC Centene Corp 2023-02-08 136,250 75.58 10,297,775
MGLN Magellan Health Inc 2020-05-15 4,500 94.99 427,455

Holding Weightings of James E Murray


James E Murray Form 4 Trading Tracker

According to the SEC Form 4 filings, James E Murray has made a total of 0 transactions in Humana Inc (HUM) over the past 5 years. The most-recent trade in Humana Inc is the sale of 31,151 shares on March 6, 2017, which brought James E Murray around $7 Million.

According to the SEC Form 4 filings, James E Murray has made a total of 1 transactions in Centene Corp (CNC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Centene Corp is the acquisition of 6,750 shares on February 8, 2023, which cost James E Murray around $494,775.

According to the SEC Form 4 filings, James E Murray has made a total of 1 transactions in Magellan Health Inc (MGLN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Magellan Health Inc is the acquisition of 4,500 shares on May 15, 2020, which cost James E Murray around $304,335.

Insider Trading History of James E Murray

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James E Murray Trading Performance

GuruFocus tracks the stock performance after each of James E Murray's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James E Murray is 2.14%. GuruFocus also compares James E Murray's trading performance to market benchmark return within the same time period. The performance of stocks bought by James E Murray within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James E Murray's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James E Murray

Average Return

21.37%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.54 2.14 7.47 21.37
Relative Return to S&P 500(%) -4.55 -7 -9.77 -12.19

James E Murray Ownership Network

Ownership Network List of James E Murray

No Data

Ownership Network Relation of James E Murray


James E Murray Owned Company Details

What does Magellan Health Inc do?

Who are the key executives at Magellan Health Inc?

James E Murray is the President and COO of Magellan Health Inc. Other key executives at Magellan Health Inc include CEO & Magellan Rx Management Mostafa Kamal , SVP & Controller Jeffrey N West , and Chief Financial Officer David Bourdon .

Magellan Health Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Magellan Health Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magellan Health Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Magellan Health Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Magellan Health Inc Insider Transactions

No Available Data

James E Murray Mailing Address

Above is the net worth, insider trading, and ownership report for James E Murray. You might contact James E Murray via mailing address: 500 West Main Street, Louisville Ky 40202.

Discussions on James E Murray

No discussions yet.